Marshall Wace North America’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RA
SM
DCM
Marshall Wace North America's ACLS Position: Q1 2021 in Review
Marshall Wace North America sold out of Axcelis (ACLS) in Q1 2021, closing a stake of 16,995 shares — an estimated $496K sold.
Marshall Wace North America first reported a position in ACLS in Q3 2017 and held it in 6 quarters. The position peaked at $5.46M in Q3 2017. 193 funds tracked by Wall St. Rank hold ACLS as of Q1 2021.
- Marshall Wace North America reported no remaining Axcelis position as of Q1 2021 after selling out during the quarter.
- Marshall Wace North America sold 16,995 Axcelis shares in Q1 2021, an estimated $496K.
- Marshall Wace North America first reported a position in Axcelis in Q3 2017 and held it in 6 quarters.
- Marshall Wace North America's Axcelis position peaked at $5.46M in Q3 2017.
- 193 funds tracked by Wall St. Rank held Axcelis as of Q1 2021.
Based on Marshall Wace North America's 13F filing for Q1 2021, filed 17 May 2021.